New Zealand markets close in 6 hours 19 minutes

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.51-0.61 (-6.69%)
At close: 04:00PM EDT
8.65 +0.14 (+1.65%)
After hours: 04:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 350.02M
Enterprise value 169.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.65
Price/book (mrq)1.66
Enterprise value/revenue -9.59
Enterprise value/EBITDA 0.11

Trading information

Stock price history

Beta (5Y monthly) 2.02
52-week change 347.33%
S&P500 52-week change 328.04%
52-week high 315.05
52-week low 31.81
50-day moving average 310.95
200-day moving average 36.36

Share statistics

Avg vol (3-month) 3242.63k
Avg vol (10-day) 3146.98k
Shares outstanding 538.38M
Implied shares outstanding 638.38M
Float 818.27M
% held by insiders 10.85%
% held by institutions 192.29%
Shares short (30 Apr 2024) 4913.55k
Short ratio (30 Apr 2024) 44.92
Short % of float (30 Apr 2024) 45.09%
Short % of shares outstanding (30 Apr 2024) 42.41%
Shares short (prior month 28 Mar 2024) 4920.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 328 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-30.67%
Return on equity (ttm)-56.79%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -101.73M
Net income avi to common (ttm)-96.02M
Diluted EPS (ttm)-4.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.64M
Total cash per share (mrq)3.28
Total debt (mrq)26.27M
Total debt/equity (mrq)20.77%
Current ratio (mrq)8.94
Book value per share (mrq)6.20

Cash flow statement

Operating cash flow (ttm)-94.18M
Levered free cash flow (ttm)-64.43M